- Home
- KNOP vs DRTS Comparison
KNOP vs DRTS Comparison
Compare KNOP & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- DRTS
- Stock Information
- Founded
- KNOP 2013
- DRTS 2015
- Country
- KNOP United Kingdom
- DRTS Israel
- Employees
- KNOP N/A
- DRTS N/A
- Industry
- KNOP Marine Transportation
- DRTS Medical/Dental Instruments
- Sector
- KNOP Consumer Discretionary
- DRTS Health Care
- Exchange
- KNOP Nasdaq
- DRTS Nasdaq
- Market Cap
- KNOP 254.2M
- DRTS 262.6M
- IPO Year
- KNOP 2013
- DRTS N/A
- Fundamental
- Price
- KNOP $6.38
- DRTS $2.93
- Analyst Decision
- KNOP
- DRTS Strong Buy
- Analyst Count
- KNOP 0
- DRTS 2
- Target Price
- KNOP N/A
- DRTS $8.00
- AVG Volume (30 Days)
- KNOP 59.9K
- DRTS 52.7K
- Earning Date
- KNOP 05-20-2025
- DRTS 05-19-2025
- Dividend Yield
- KNOP 1.63%
- DRTS N/A
- EPS Growth
- KNOP N/A
- DRTS N/A
- EPS
- KNOP 0.19
- DRTS N/A
- Revenue
- KNOP $320,026,000.00
- DRTS N/A
- Revenue This Year
- KNOP $5.04
- DRTS N/A
- Revenue Next Year
- KNOP $1.00
- DRTS N/A
- P/E Ratio
- KNOP $33.84
- DRTS N/A
- Revenue Growth
- KNOP 8.76
- DRTS N/A
- 52 Week Low
- KNOP $5.28
- DRTS $1.75
- 52 Week High
- KNOP $9.11
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- KNOP 50.65
- DRTS 52.34
- Support Level
- KNOP $6.21
- DRTS $2.95
- Resistance Level
- KNOP $6.48
- DRTS $3.12
- Average True Range (ATR)
- KNOP 0.20
- DRTS 0.20
- MACD
- KNOP -0.03
- DRTS -0.01
- Stochastic Oscillator
- KNOP 40.91
- DRTS 24.00
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.